Pharmaceutical Outsourcing Part 2: An Introduction to Drug Discovery Strategies new opportunities lie in a fully integrated global outsourcing strategy

Introduction

The pharma industry is facing a crisis over R&D productivity, as reflected by the low level of new drug approvals despite companies investing the highest ever amounts in R&D. As a result, companies are seeking novel ways to drive growth, with many opting to increase their reliance on third parties - through licensing, collaborative and outsourcing agreements - in an attempt to achieve this.

Scope of this report

• Evaluation of the key benefits and risks associated with outsourcing drug discovery functions
• In-depth country profiles examining the suitability of key emerging countries for outsourcing drug discovery work, including China, India, and Russia
• Case study analysis evaluating how companies use drug discovery outsourcing in practice
• Key recommendations on how companies can optimize their drug discovery outsourcing strategy and realize the full value it offers

Research and analysis highlights

The emergence of countries such as China and India as suitable destinations for drug discovery outsourcing is creating new opportunities for foreign pharma and biotech companies to achieve cost savings as well as increase their overall R&D productivity, but companies must still proceed cautiously, as there are particular risks in these countries.

With the increasing globalization of the drug discovery service market, pharma and biotech companies must look to fully integrate global outsourcing into their drug discovery strategy to be able to exploit the full spectrum of benefits that different countries offer with respect to drug discover services.

Companies need to ensure they are realizing the maximum value that outsourcing drug discovery functions offers. As a result companies need to ensure they are using outsourcing strategically where possible, creating a robust screening process for vendors as well as using an effective management and monitoring system for external alliances.

Key reasons to read this report

• Identify the best way to tackle the common reasons why outsourcing agreements fail to live up to the customer's expectations
• Assess the commercial implications of the increasing globalization of the outsourcing market for drug discovery services
• Understand how to optimize the use of outsourcing in your drug discovery strategies to capture the maximum benefit